FindTrial
Sign In

Evaluating utility of Oestrogen and Progesterone Receptor biomarkers for prediction of colorectal Cancer

To study the utility of Estrogen Receptor and Progesterone Receptor expression as an immunohistochemical predictive markers for tumour behaviour in comparison to histopathological parameters and Tumour, Lymph Node and Metastatic staging in colorectal carcinoma - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/068054
Enrollment
55
Registered
2024-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C189- Malignant neoplasm of colon, unspecified Health Condition 2: C20- Malignant neoplasm of rectum

Interventions

Control Intervention1: NIL: NIL

Sponsors

Datta Meghe Institute of Higher Education & Research (DMIHER)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Previously diagnosed as Colorectal carcinoma on histopathology 2) All colorectal carcinoma cases that are operated 3) Colorectal carcinoma cases that are primary cases and have not received any previous treatment 4) All patients diagnosed with colorectal carcinoma occurring spontaneously.

Exclusion criteria

Exclusion criteria: 1) All non-cancerous lesions found in the colon and rectum 2) All previously treated cases of colorectal carcinoma 3) All patients with colorectal carcinoma experiencing cancer recurrence 4) Patients lacking histological confirmation of colorectal carcinoma.

Design outcomes

Primary

MeasureTime frame
ER and PR immunohistochemistry for detecting its expression and to correlate the tumour behaviour in comparison to histopathological grading and TNM staging in Colorectal carcinoma.Timepoint: 2 years—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactSneha Sukumar

Datta Meghe Institute of Higher Education & Research (DMIHER)

samarth21174@gmail.com8830267710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026